Matthew J Nyflot1, Tzu-Cheng Lee2, Adam M Alessio3, Scott D Wollenweber4, Charles W Stearns4, Stephen R Bowen5, Paul E Kinahan3. 1. Department of Radiation Oncology, University of Washington, Seattle, Washington 98195-6043. 2. Department of Bioengineering, University of Washington, Seattle, Washington 98195-6043. 3. Department of Radiology, University of Washington, Seattle, Washington 98195-6043. 4. GE Healthcare, Waukesha, Wisconsin 53188. 5. Department of Radiation Oncology, University of Washington, Seattle, Washington 98195-6043 and Department of Radiology, University of Washington, Seattle, Washington 98195-6043.
Abstract
PURPOSE: Respiratory-correlated positron emission tomography (PET/CT) 4D PET/CT is used to mitigate errors from respiratory motion; however, the optimal CT attenuation correction (CTAC) method for 4D PET/CT is unknown. The authors performed a phantom study to evaluate the quantitative performance of CTAC methods for 4D PET/CT in the ground truth setting. METHODS: A programmable respiratory motion phantom with a custom movable insert designed to emulate a lung lesion and lung tissue was used for this study. The insert was driven by one of five waveforms: two sinusoidal waveforms or three patient-specific respiratory waveforms. 3DPET and 4DPET images of the phantom under motion were acquired and reconstructed with six CTAC methods: helical breath-hold (3DHEL), helical free-breathing (3DMOT), 4D phase-averaged (4DAVG), 4D maximum intensity projection (4DMIP), 4D phase-matched (4DMATCH), and 4D end-exhale (4DEXH) CTAC. Recovery of SUV(max), SUV(mean), SUV(peak), and segmented tumor volume was evaluated as RC(max), RC(mean), RC(peak), and RC(vol), representing percent difference relative to the static ground truth case. Paired Wilcoxon tests and Kruskal-Wallis ANOVA were used to test for significant differences. RESULTS: For 4DPET imaging, the maximum intensity projection CTAC produced significantly more accurate recovery coefficients than all other CTAC methods (p < 0.0001 over all metrics). Over all motion waveforms, ratios of 4DMIP CTAC recovery were 0.2 ± 5.4, -1.8 ± 6.5, -3.2 ± 5.0, and 3.0 ± 5.9 for RC(max), RC(peak), RC(mean), and RC(vol). In comparison, recovery coefficients for phase-matched CTAC were -8.4 ± 5.3, -10.5 ± 6.2, -7.6 ± 5.0, and -13.0 ± 7.7 for RC(max), RC(peak), RC(mean), and RC(vol). When testing differences between phases over all CTAC methods and waveforms, end-exhale phases were significantly more accurate (p = 0.005). However, these differences were driven by the patient-specific respiratory waveforms; when testing patient and sinusoidal waveforms separately, patient waveforms were significantly different between phases (p < 0.0001) while the sinusoidal waveforms were not significantly different (p = 0.98). When considering only the subset of 4DMATCH images that corresponded to the end-exhale image phase, 4DEXH, mean and interquartile range were similar to 4DMATCH but variability was considerably reduced. CONCLUSIONS: Comparative advantages in accuracy and precision of SUV metrics and segmented volumes were demonstrated with the use of the maximum intensity projection and end-exhale CT attenuation correction. While respiratory phase-matched CTAC should in theory provide optimal corrections, image artifacts and differences in implementation of 4DCT and 4DPET sorting can degrade the benefit of this approach. These results may be useful to guide the implementation, analysis, and development of respiratory-correlated thoracic PET/CT in the radiation oncology and diagnostic settings.
PURPOSE: Respiratory-correlated positron emission tomography (PET/CT) 4D PET/CT is used to mitigate errors from respiratory motion; however, the optimal CT attenuation correction (CTAC) method for 4D PET/CT is unknown. The authors performed a phantom study to evaluate the quantitative performance of CTAC methods for 4D PET/CT in the ground truth setting. METHODS: A programmable respiratory motion phantom with a custom movable insert designed to emulate a lung lesion and lung tissue was used for this study. The insert was driven by one of five waveforms: two sinusoidal waveforms or three patient-specific respiratory waveforms. 3DPET and 4DPET images of the phantom under motion were acquired and reconstructed with six CTAC methods: helical breath-hold (3DHEL), helical free-breathing (3DMOT), 4D phase-averaged (4DAVG), 4D maximum intensity projection (4DMIP), 4D phase-matched (4DMATCH), and 4D end-exhale (4DEXH) CTAC. Recovery of SUV(max), SUV(mean), SUV(peak), and segmented tumor volume was evaluated as RC(max), RC(mean), RC(peak), and RC(vol), representing percent difference relative to the static ground truth case. Paired Wilcoxon tests and Kruskal-Wallis ANOVA were used to test for significant differences. RESULTS: For 4DPET imaging, the maximum intensity projection CTAC produced significantly more accurate recovery coefficients than all other CTAC methods (p < 0.0001 over all metrics). Over all motion waveforms, ratios of 4DMIPCTAC recovery were 0.2 ± 5.4, -1.8 ± 6.5, -3.2 ± 5.0, and 3.0 ± 5.9 for RC(max), RC(peak), RC(mean), and RC(vol). In comparison, recovery coefficients for phase-matched CTAC were -8.4 ± 5.3, -10.5 ± 6.2, -7.6 ± 5.0, and -13.0 ± 7.7 for RC(max), RC(peak), RC(mean), and RC(vol). When testing differences between phases over all CTAC methods and waveforms, end-exhale phases were significantly more accurate (p = 0.005). However, these differences were driven by the patient-specific respiratory waveforms; when testing patient and sinusoidal waveforms separately, patient waveforms were significantly different between phases (p < 0.0001) while the sinusoidal waveforms were not significantly different (p = 0.98). When considering only the subset of 4DMATCH images that corresponded to the end-exhale image phase, 4DEXH, mean and interquartile range were similar to 4DMATCH but variability was considerably reduced. CONCLUSIONS: Comparative advantages in accuracy and precision of SUV metrics and segmented volumes were demonstrated with the use of the maximum intensity projection and end-exhale CT attenuation correction. While respiratory phase-matched CTAC should in theory provide optimal corrections, image artifacts and differences in implementation of 4DCT and 4DPET sorting can degrade the benefit of this approach. These results may be useful to guide the implementation, analysis, and development of respiratory-correlated thoracic PET/CT in the radiation oncology and diagnostic settings.
Authors: U Nestle; K Walter; S Schmidt; N Licht; C Nieder; B Motaref; D Hellwig; M Niewald; D Ukena; C M Kirsch; G W Sybrecht; K Schnabel Journal: Int J Radiat Oncol Biol Phys Date: 1999-06-01 Impact factor: 7.038
Authors: Hua Li; Wade L Thorstad; Kenneth J Biehl; Richard Laforest; Yi Su; Kooresh I Shoghi; Eric D Donnelly; Daniel A Low; Wei Lu Journal: Med Phys Date: 2008-08 Impact factor: 4.071
Authors: Wouter van Elmpt; Dirk De Ruysscher; Anke van der Salm; Annemarie Lakeman; Judith van der Stoep; Daisy Emans; Eugène Damen; Michel Öllers; Jan-Jakob Sonke; José Belderbos Journal: Radiother Oncol Date: 2012-04-06 Impact factor: 6.280
Authors: Adam M Alessio; Steve Kohlmyer; Kelley Branch; Grace Chen; James Caldwell; Paul Kinahan Journal: J Nucl Med Date: 2007-05 Impact factor: 10.057
Authors: J F Vansteenkiste; S G Stroobants; P R De Leyn; P J Dupont; J Bogaert; A Maes; G J Deneffe; K L Nackaerts; J A Verschakelen; T E Lerut; L A Mortelmans; M G Demedts Journal: J Clin Oncol Date: 1998-06 Impact factor: 44.544
Authors: Qinghui Zhang; Alex Pevsner; Agung Hertanto; Yu-Chi Hu; Kenneth E Rosenzweig; C Clifton Ling; Gig S Mageras Journal: Med Phys Date: 2007-12 Impact factor: 4.071
Authors: Onofrio A Catalano; Lale Umutlu; Niccolo Fuin; Matthew Louis Hibert; Michele Scipioni; Stefano Pedemonte; Mark Vangel; Andreea Maria Catana; Ken Herrmann; Felix Nensa; David Groshar; Umar Mahmood; Bruce R Rosen; Ciprian Catana Journal: Eur J Nucl Med Mol Imaging Date: 2018-07-11 Impact factor: 9.236
Authors: Jaewon Yang; Jing Liu; Florian Wiesinger; Anne Menini; Xucheng Zhu; Thomas A Hope; Youngho Seo; Peder E Z Larson Journal: Phys Med Biol Date: 2018-09-10 Impact factor: 3.609